Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex

Kirk Jensen (Inventor)

Research output: Patent

18 Downloads (Pure)


This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cells
ghosts, glioblastomas, and lymphomas are described.
Original languageEnglish
Patent numberAU 732961 B2
IPCAU 732961 B2
Publication statusPublished or Issued - 3 May 2001

Cite this